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Injection of concentrated EBV derived jkom cells of the Kaplan line of infectious 
mononucleosis ( I M )  origin resulted in malignant lymphoproliferation in one out of 
three cotton-top marmosets 6 weeks after inoculation. Two additional animals receiving 
the same isolate after incubation with an antibody-containing human serum did not 
develop tumors. Inoculation of concentrated virus derived from the P3HR-I line of 
Burkitt origin did not lead to Iymphoprolijeration in five marmosets. Three of these 
received non-neutralized, and two received neutralized P3H R-1 virus. The tumor obtained 
with the Kaplan isolate revealed characteristics of a lymphosarcoma. It contained 
EB V-specific DNA. I n  addition, EB V-synthesizing lymphoblastoid lines were established 
from a tumorous lymph-node, as well as from the spleen of the diseased marmoset. 
Virus recovered from these lines transjormed lymphocytes derived from spleens of 
healthy marmosets. The tumor-bearing animal developed low levels of anti- VCA anti- 
bodies during the course of tumor growth. These data demonstrate the oncogenic potential 
of EBV directly derived fvom cells of I M  origin. 
The etiological relationship of Epstein-Barr 
virus (EBV) to infectious mononucleosis ( I  M) 
has been firmly established (Henle et al., 1968; 
Niederman et al., 1968; Henle and Henle, 1970, 
1971; Evans, 1974). EBV is also regularly 
demonstrated in another lymphoproliferative 
disease, Burkitt’s lymphoma (BL) and in ana- 
plastic nasopharyngeal carcinoma ( N P C )  (Henle 
et al., 1968; de Schryver et al., 1969; zur Hausen 
et al., 1970; Wolf et a[., 1973; zur Hausen et al., 
1974). Further proof of its oncogenicity was 
hampered by the lack of a suitable laboratory 
animal system. Infection of lymphocytes and 
subsequent transformation of cells derived from 
peripheral blood or spleen could be demonstrated 
for six sub-human primate species: gibbon, 
squirrel, cotton-top and white-lipped marmosets, 
cinnamon ringtail and owl monkeys (Falk et al., 
1972; Wolfe and Deinhardt, 1973; Deinhardt et 
al., 1974; Werner et al., 1972a). 
Recently overt clinical illness has been reported 
in non-human primates after exposure to cell-free 
EBV or EBV-containing material (Shope et al., 
1973; Epstein et al., 1973a; Falk et al., 1974). 
Shope and co-workers induced malignant lym- 
phomas in four of eight cotton-top marmosets 
by inoculation of cell-free virus extracted from 
a marmoset lymphoblastoid line 895-8 originally 
transformed in vitro (Miller et al., 1972) by EBV 
isolated from an IM cell line. These results were 
confirmed by Falk and his colleagues, also using 
B95-%derived virus in cotton-top marmosets. 
Epstein and his group inoculated owl monkeys 
with frozen and thawed EB3 cells of Burkitt 
origin and observed lymphoproliferative disease 
in one of three animals. These results indicate 
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that marmosets may provide an excellent labora- 
tory model to study further the biological 
properties of different EBV preparations in vivo. 
This report deals with responses of cotton-top 
marmosets to inoculation of two different prep- 
arations of EBV, of which one was active while 
the other had been exposed to EBV-specific 
antibody-containing human serum. 
MATERIAL AND METHODS 
Marmosets 
Wild-caught, adult cotton-top marmosets 
(Saguinus oedipus) from Colombia, South 
America, were used in these experiments. The 
animals had been conditioned for laboratory use 
and were free of detectable antibodies against 
EBV. 
Virus 
Cells and supernatants (1,400 ml total vol. of 
each culture) of aged P3HR-1 cultures of BL 
origin (Hinuma et al., 1967) and of the IM-derived 
Kaplan line (Diehl ef al., 1968) were subjected to 
differential centrifugation. After clarification at 
low speed, the virus was concentrated from the 
culture fluid at 36,000 x g  for 2 h at 4" C in the 
No. 19 rotor of the Beckman preparative cen- 
trifuge. In addition, the cell pellet was resus- 
pended in 15 ml reticulocyte standard buffer 
(RSB) containing 0.01 M NaCI, 0.0015 M MgC12, 
0.01 M Tris HCI PH 7.4, and kept at 4" C for 3 h, 
then dounced brieflly and indirectly sonicated 
with the Branson macrotip sonifier for. 1 min at 
position 4. After low-speed centrifugation the 
RSB-supernatant was pooled with the resus- 
pended virus pellet recovered from the first high- 
speed run. The pooled material was then spun 
at 80,OOOxg for 1 h at 4" C in the Beckman 
SW 27 rotor. The resulting pellet was resus- 
pended in 2.2 ml of phosphate-buffered saline 
(PBS), dounced 10 times and passed through a 
1.2 ,u membrane filter. 
Corresponding preparations of P3HR-1 virus 
induced early antigens (EA) in about 20% of 
infected Raji cells 72 h post infection (PI) with 
the undiluted virus. The Kaplan concentrate 
transformed umbilical cord lymphocytes at a 
very low efficiency (dilutions loo to 10-l). The 
P3HR-1 line contained at the time of harvest 
about 5 % viral capsid antigen (VCA)-positive 
cells, whereas the Kaplan line revealed approxi- 
mately 0.1 % VCA-positive cells as measured by 
immunofluorescence (IF). 
Neutralization 
Equal volumes of each virus preparation were 
incubated for 1 h at 37" C with the same amount 
of human EBV-reactive or non-reactive serum. 
The EBV-reactive serum revealed an anti-VCA 
titer of 1 :320, and an anti-EA titer of I :2. The 
non-reactive serum contained less than 1 5  of 
anti-VCA activity. 
Inoculation of marmosets and follow-up studies 
Ten randomly-selected male and female 
marmosets were inoculated with EBV prepara- 
tions by the intramuscular route. Each of the 
P3HR-1 and Kaplan viral preparations was 
injected into three marmosets. Two additional 
animals received the appropriate virus inoculum 
after treatment of the concentrate with human 
anti-EBV serum. Equal amounts of active as well 
as non-active virus were injected into the left 
masseter muscle of the marmosets. The animals 
were bled from the femoral triangle at weekly 
intervals for white blood cell (WBC) counts and 
for antibody determinations. At each bleeding 
the marmosets were closely examined for evidence 
of tumor formation, as well as for clinical 
symptoms which might be referable to EBV 
infection. Blood samples obtained were examined 
for hematological abnormalities and antibody 
activity referable to EBV infection. 
Immunofluorescence 
For antibody determination, sera collected 
from the marmosets were tested by the indirect 
immunofluorescence (IF) techniques described 
by the Henles (Henle and Henle, 1966). Goat 
anti-human IgG conjugate (Hyland Laboratories, 
Los Angeles, Calif., USA) was used throughout 
the tests. For detection of EB viral antigens in 
cultured tumor cells, acetone-fixed smears were 
prepared as described (Henle et al., 1969) and 
stained by direct and/or indirect I F  techniques 
for VCA and EA (Henle et al., 1970). As a 
control we included a marmoset serum which 
was free of detectable antibodies to EBV antigens 
but contained antibodies to herpesvirus saimiri 
(HVS). Other smears were stained solely with 
anti-human IgG conjugate for the presence of 
immunoglobulins. 
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Histolopv twice in PBS. resusoended in 0.5 rnl PBS and 
At autopsy, material from tumor, spleen and 
lymph nodes was removed and fixed for 5 days 
in buffered formaldehyde solution (4%). The 
specimens were then processed for light micro- 
scopy using hematoxylin-eosin staining. 
Hematology 
Air-dried smears of peripheral blood drawn at 
weekly intervals were stained according to the 
May-Grunwald technique. Differential counts of 
WBC were recorded and compared with baseline 
data obtained in our laboratory. 
Cytology 
For exclusion of T-cell markers the procedure 
of Lay et al. (1971) with the modifications of 
Schwenk et al. (1974) was employed with minor 
changes. About 2 x lo6 cells from rapidly growing 












incubated with an equal volume of 0.5% sheep 
red blood cell (SRBC) suspension for 5 min in a 
water bath at 37" C with continuous shaking. 
The cells were then pelleted at 200 x g  and kept 
at 4" C for 1 h. After gentle resuspending they 
were transferred to a cell counting chamber and 
examined for rosette formation. For studies of 
cell morphology, smears were stained by the 
conventional Leishman-G iemsa technique. 
Electron microscopy 
Negative staining of concentrated virus was 
performed by the common two-step procedure 
using 2% phosphotungstic acid (PTA) at PH 7.0 
and 7.5 on copper grids coated with Piolofirm 
(Wacker Chemie GmbH., Munich, Germany) 
and carbon. Negative stainings were examined 
for the presence of viral particles with a Siemens 
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FIGURE 1 
Total WBC, lymphocyte and monocyte counts, as well as development of 
VCA-antibodies within the tumor-bearing marmoset following injection of 
active Kaplan virus. 
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Lymphocyte cultures 
Lymphocytes were isolated at autopsy from 
parts of the tumor and spleen. The tissue frag- 
ments were minced and teased through a fine 
teflon-coated steel mesh into medium RPMI 1640 
without fetal calf serum (FCS), containing 1 % 
glutamine, 20 mM HEPES, 50 ,ug/ml gentamycin 
and 2.5 ,ug/ml amphotericin B. The cell suspen- 
sions were then layered on Ficoll-Hypaque 
gradients (Perper et al., 1968; Thorsby and 
Bratlie, 1970), = 1.077 g/ml, and spun at 
200 x g  for 25 min at room temperature. Separated 
lymphocytes were collected, washed three times 
in medium and resuspended in 3.0-5.0mI of 
growth medium RPMI supplemented with 10% 
FCS, 1 % glutamine and 100 ,ug/ml ampicillin. 
Cultures were set up in duplicate and incubated 
at 37" C in a 5 %  C0,-enriched atmosphere. 
Normal splenic lymphocytes for in vitro trans- 
formation assay were prepared and handled as 
above. Cultures were fed weekly by replacing 
50% of the supernatant with fresh pre-warmed 
medium. Cell proliferation, as revealed by cluster 
formation and blastoid transformation, was 
monitored with a Leitz inverted microscope. 
RESULTS 
No signs of clinical disease and no evidence of 
seroconversion were observed in the animals 
which received P3HR-1 virus or neutralized 
Kaplan virus. The same held true for two 
marmosets inoculated with active Kaplan virus. 
In one marmoset exposed to non-neutralized 
Kaplan virus, a marked change in the differential 
count of WBC was seen 5 weeks PI (Fig. 1) .  The 
number of lymphocytes dropped from about 
60% to 23% and monocytes increased to 7%. 
One week later these values had returned to 
normal. At this time, however, enlargement of 
lymph nodes in the cervical region was discovered 
and low titers (15) of serum antibodies to 
EB-VCA could be demonstrated. During the 
next 2 weeks accelerated tumor growth was 
recorded, involving the right submandibular 
FIGURE 2 
Close-up of the cervical region of marmoset 794; A:  tumor appearance 9 weeks after inoculation; 
B :  view of tumor and enlarged lymph glands (between arrows) at autopsy. Normal salivary gland, small arrow. 
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region. Eight weeks PI a solid tumor approxi- 
mately 0.6 cm in diameter had developed. Tumor 
masses were also palpated in the left cervical 
region encompassing the draining lymph nodes 
at the site of inoculation. The lymphocyte count 
rose to 82% with a few atypical cells present, 
and serum antibodies to VCA reached a titer of 
I :lo. At week 9 PI the moribund marmoset was 
killed. At that time the WBC differential count 
revealed numerous atypical lymphocytes and the 
last available serum contained antibodies to VCA 
at a titer of 1 :20. 
At autopsy the cervical lymph nodes were 
found to be enlarged up to 0.5 cm in diameter. 
A solid tumor measuring 1.0 cm across with 
necrosis and hemorrhage, involving the right 
submandibular gland, was detected (Fig. 2). The 
spleen was swollen, measuring more than twice 
its normal size, with tiny superficial nodules and 
occasional necrosis. 
Tumor, lymph nodes, liver and spleen were 
removed for further studies. 
Histologic examination of the tumorous lymph 
node revealed neoplastic changes of tissue as 
indicated by numerous foci composed of lym- 
phocytic and reticulum cells embedded in large 
zones of necrotic material (Fig. 3~). The nucleus 
of the prominent cell type was large with margi- 
nated chromatin. Many nuclei contained multiple 
nucleoli. Mitotic figures were present (Fig. 3 ~ - c ) .  
The same cell type was also noted in lymph 
nodes and spleen, although typical foci of 
tumorous tissue were not recognizable. The liver 
exhibited lymphocytic infiltrations in the peri- 
portal zones but no tumorous alterations were 
seen in various sections examined. 
Data on nucleic acid hybridization performed 
with DNA from the biopsy material and EBV- 
DNA labelled in vitvo are reported elsewhere 
(Wolf et a/., 1975). They showed the presence of 
virus-specific DNA within the tumor material as 
well as within DNA derived from the infiltrated 
spleen. 
Cell cultures were initiated from small pieces 
of tumor and spleen, as well as from peripheral 
blood. Cell proliferation was observed after 
70 days in the tumor-derived culture and after 
80 days in the spleen-derived culture. No lympho- 
blastoid cell lines could be established from 
peripheral blood. 
Both established lines, 794T (tumor) and 7948 
(spleen), showed the presence of EBV antigen- 
containing cells ranging from 3 to 5 %  of the 
total cell population. Cells containing EA usually 
exceeded the number of VCA-positive cells. 
Production of IgC was found in both lines at an 
early stage of cultivation in a low percentage 
(0.1 to  0.5 %). None of the lines formed rosettes 
with SRBC. The cell population consisted of 
predominantly large blastic cells, with irregular- 
shaped nuclei containing one or more nucleoli. 
The cytoplasm stained intensely blue (Leishman- 
Giemsa) and contained a number of small 
vacuoles. Giant cells with multilobed nuclei were 
also present (Fig. 4). Cells thus closely resembled 
cultured BL cells on the basis of their rnorpho- 
logical features (Epstein et a/., 1966; Pope et al., 
1967). 
In concentrated supernatants of both lines, as 
well as in sectioned cells, virus particles of herpes 
morphology could be detected by electron 
microscopy (Fig. 5) .  
For transformation of normal marmoset spleen 
lymphocytes, supernatants of aged cultures of 
794s cells were concentrated, as described in 
" Material and Methods ", to yield cell-free 
preparations of EBV. The lymphocytes were 
exposed to 0.2ml of this virus preparation for 
2 h at 37" C and subsequently treated as reported 
above. Four weeks after infection of the cells, a 
lymphoblastoid line 7863 became established. 
These cells produced EBV-related EA and VCA, 
as revealed by IF techniques in 5 to 10% of the 
population. No cell growth was observed with 
uninfected 786 lymphocytes cultivated in parallel. 
DISCUSSION 
Our data indicate that EBV derived from 
tissue-culture cells of a patient with IM can 
induce lymphoproliferative disease as expressed 
FIGURE 3
A :  Histologic section of tumor from marmoset 794. Foci of tumor cells surrounded by necrotic tissue. 
Heniatoxylin and eosin, x 100. a-r: Higher magnification of tumorous foci composed of lymphocytic and 
reticulum cells, x 500. 
1004 
EB VIRUS-INDUCED LYMPHOPROLIFERATION 
1005 
WEKNEK ET AL. 
FIGURE 4
tumor rnatcrial )i ; ,800. 
F I G U R ~  5 
moset tumor after negative contrast staining, 
Lzishman-Giernsa staining of lyrnphoblastoid tissue culture cells obtained after in vitro cultivation of 
Virus particles, isolated from the supernatant of the 794T lymphoblastoid line, established from the niai - 
120,000. 
by tumor formation in cotton-top marmosets. 
This is in line with the observations of Shope et 
a/. (1973), Epstein ef a/., (19736) and Falk ef a/. 
(1974) who induced tumors in the same species 
or  in an owl monkey, after inoculation of EBV 
obtained either from an in vi/ro-transformed 
marmoset cell line or  from EB3 cells of Burkitt 
tumor origin. Thus, a virus originating from 
human non-malignant disease may be oncogenic 
for primates under experimental conditions. 
The cellular heterogeneity of the lesion 
encountered in marmoset No. 794 is consistent 
with malignant lymphosarcoma. The tumorous 
material contained EBV-DNA as demonstrated 
by nucleic acid hybridization (Wolf et af., 1975), 
and gave rise to lymphoblastoid cell lines syn- 
thesizing EBV in 3 to 5 %  of the cells. The virus 
isolated from a line derived from the infiltrated 
spleen also induced transformation of normal 
marmoset spleen lymphocytes. The tumor-bearing 
animal developed low titers of antibodies to 
EB-VCA in the course of the disease. 
The induction of tumor in one of the three 
marmosets inoculated with active Kaplan virus 
is rather surprising in view of the low in vitro 
transforming efficiency of this isolate. The latter 
appears to  be due to  the low spontaneous 
induction rate of the line as revealed by VCA- 
immunofluorescence. This might also account for 
the failure to  induce tumors in marmosets with 
other Kaplan concentrates as reported by Falk 
and his colleagues (1974). 
The animals injected with the P3HR-I isolate 
should have received a t  least 100 times more virus 
particles, by assuming equal amounts of virus 
synthesis in VCA-positive P3HR-I and Kaplan 
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cells. The consistent failure to induce tumors with 
this preparation (Werner et al., 19726; Falk et al., 
1974) corresponds to the lack of transforming 
activity after infection of umbilical cord lympho- 
cytes (Klein et al., 1972; Miller et al., 1972). The 
marmoset system appears to offer an approach 
to test strain differences of various EBV isolates. 
Neutralization tests performed in our studies 
were definitely hampered by the small number of 
available marmosets and therefore are not very 
indicative. 
In conclusion, we demonstrated tumor induc- 
tion in one of three cotton-top marmosets after 
inoculation with EBV derived from a cell line of a 
patient suffering from IM. Virus isolates from 
P3HR-1 cells of BL origin failed to induce 
lymphoproliferative disease in a small number of 
animals tested. 
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MALADIE LYMPHOPROLIFERATIVE CHEZ UN OUISTITI DE L'ESPECE 
SAGUZNUS OEDZPUS APRES INOCULATION AVEC LE VIRUS 
D'EPSTEIN-BARR PROVENANT D'UNE MONONUCLEOSE INFECTIEUSE 
L'injection d'EBV concentre' provenant de cellules de la ligne'e Kaplan obtenue ci 
partir d'une mononucle'ose infectieuse a provoqut! une lymphoprolife'ration maligne chez 
un ouistiti sur trois, six semaines aprks I'inoculation. Deux autres animaux qui avaient 
r e p  le mtme isolat aprts incubation avec du se'rum humain contenant des anticorps 
n'ont pas de'veloppe' de tumeurs. L'inoculation de virus concentre' provenant de la ligne'e 
p 3HR-I de lymphome de Burkitt n'a pas induit de lymphoprolije'ration chez cinq 
ouistitis. Trois d'entre eux ont r e p  du virus P3HR-I non neutralist! et les deux autres 
du virus neutralist. La tumeur obtenue avec I'isolat Kaplan avait les caracte'ristiques 
d'un lymphosarcome. Elk contenait 1'AD N sptcifque de I'EB V. En outre, des ligne'es 
lymphoblastoides synthttisant I'EB V ont t t t  constitutes ri partir d'un ganglion cance'rise' 
ainsi que de la rate du singe canckreux. Le virus recueilli dans ces ligne'es a transform6 
des lymphocytes provenant de la rate de ouistitis sains. Chez I'animal canctreux, les 
titres d'anticorps anti- VCA ont PtP faibles pendant toute la dure'e de la croissance tumo- 
rale. Ces observations mettent en e'vidence le potentiel oncogtnique de I'EB V directe- 
ment obtenu a partir de cellules de mononucltose infectieuse. 
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